Physician profile
Chadwick A Smith
NPI 1326012519
$12,565.34
in general payments reported to CMS, 2019-2025
31 companies · $5,381 in 2025
The $5,381 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,475 · 2020: $1,530 · 2021: $2,866 · 2022: $180 · 2023: $809 · 2024: $324 · 2025: $5,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,523 · Food and Beverage: $2,491 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,522.61 |
| Food and Beverage | $2,490.87 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,258.05 | 2021-2025 | Acufex Meniscal Root Repair, Healicoil, Q-Fix |
| Arthrex, INC. | $2,847.12 | 2019-2020 | |
| Alpha Orthopedic Systems | $2,508.54 | 2021 | |
| Synthes Gmbh | $2,309.12 | 2025 | |
| Smoky Mountain Surgical LLC | $409.64 | 2023-2025 | |
| Linvatec Corporation | $182.02 | 2023 | Biobrace 23mm |
| Globus Medical, INC. | $158.93 | 2023-2025 | Distal Radius Plate, Anthem, Troch Nail |
| Innovation Technologies INC | $113.76 | 2025 | Irrisept |
| Kowa Pharmaceuticals America, INC. | $113.48 | 2020-2023 | Seglentis |
| Pacira Therapeutics, INC. | $77.57 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $67.39 | 2020-2022 | |
| Amarin Pharma, INC. | $59.31 | 2020-2022 | |
| Moximed, INC | $59.18 | 2025 | Misha Knee System, Small, Left |
| Djo, LLC | $57.84 | 2024-2025 | Cmf |
| Takeda Pharmaceuticals U.S.A., INC. | $55.52 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $34.14 | 2021 | |
| Esperion Therapeutics, INC. | $28.37 | 2021 | |
| Medacta USA, INC. | $24.95 | 2021 | |
| Boston Scientific Corporation | $23.80 | 2023 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $18.79 | 2023 | Kyphon Express II Kyphopak Tray |
| Janssen Pharmaceuticals, INC | $18.40 | 2020 | |
| Amgen INC. | $18.36 | 2021 | |
| Depuy Synthes Sales INC. | $18.19 | 2022 | |
| Avanos Medical | $16.45 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.28 | 2021 | |
| Abbvie INC. | $14.16 | 2022 | |
| Bioventus LLC | $13.10 | 2023 | Exogen Ultrasound Bone Healing System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.69 | 2021 | |
| Horizon Therapeutics Plc | $12.02 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.19 | 2021 | |
| Orthofix Medical, INC. | $8.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadwick Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.